Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (9)
  • PROTACs
    (4)
  • DNA/RNA Synthesis
    (3)
  • Epigenetic Reader Domain
    (3)
  • HDAC
    (3)
  • Histone Demethylase
    (3)
  • Immunology/Inflammation related
    (3)
  • MDM-2/p53
    (3)
  • ADC Antibody
    (2)
  • Others
    (20)
Filter
Search Result
Results for "

acute lymphoblastic leukemia

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    45
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    5
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    1
    TargetMol | Dye_Reagents
  • PROTAC Products
    5
    TargetMol | PROTAC
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
  • Cell Research
    2
    TargetMol | Inhibitors_Agonists
L-Asparaginase
L-​ASNase
TP11159015-68-3
L-Asparaginase (L-ASNase) (L-ASNase), a hydrolase that catalyzes the conversion of L-asparagine, used in acute lymphoblastic leukemia treatment.Asparaginase is an enzyme that is used as a medication. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin.
  • $55
In Stock
Size
QTY
Terminal deoxyribonucleotidyltransferase
TdT
TRP-003469027-67-2
Terminal deoxyribonucleotidyltransferase (TdT) catalyzes the addition of deoxyribonucleotide triphosphates to the 3' hydroxyl terminus of a DNA chain and introduces N regions at gene segment junctions during V(D)J recombination. It is expressed in immature, pre-B, and pre-T lymphocytes, as well as in acute lymphoblastic leukemia/lymphoma cells.
    Inquiry